SMTL ID : 7zqx.1

Human galectin-3c in complex with a galactose derivative

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.05 Å

Oligo State

monomer

Ligands

1 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 7 residues within 4Å: Chain A: A.34, D.36, V.43, H.46, K.64, W.69 Ligands: JU0.6 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:D.36, A:H.46, A:K.64 Water bridges: A:K.64, A:W.69, A:S.125

1 x SCN: THIOCYANATE ION(Non-functional Binders)

SCN.2: 4 residues within 4Å: Chain A: R.32, N.48, R.50 Ligands: JU0.6 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:R.32

3 x CL: CHLORIDE ION(Non-functional Binders)

CL.3: 2 residues within 4Å: Chain A: S.134, Y.135 Ligand excluded by PLIP CL.4: 1 residues within 4Å: Chain A: R.71 Ligand excluded by PLIP CL.5: 3 residues within 4Å: Chain A: V.113, K.114, K.115 Ligand excluded by PLIP

1 x JU0: (2~{R},3~{R},4~{S},5~{R},6~{R})-2-(5-bromanylpyridin-3-yl)sulfanyl-6-(hydroxymethyl)-4-[4-[3,4,5-tris(fluoranyl)phenyl]-1,2,3-triazol-1-yl]oxane-3,5-diol(Non-covalent)

JU0.6: 15 residues within 4Å: Chain A: R.32, I.33, A.34, H.46, N.48, R.50, N.62, W.69, G.70, E.72, S.125, G.126 Ligands: GOL.1, SCN.2, MOH.7 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:A.34, A:W.69 Hydrogen bonds: A:R.50, A:N.62 pi-Cation interactions: A:R.32, A:H.46

1 x MOH: METHANOL(Non-functional Binders)

MOH.7: 4 residues within 4Å: Chain A: R.50, E.72, R.74 Ligands: JU0.6 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.50, A:R.50, A:R.74 Water bridges: A:E.53

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zetterberg, F.R. et al., Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease. J.Med.Chem. (2022)

Release Date

2022-11-02

Peptides

Galectin-3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Galectin-3

Related Entries With Identical Sequence